| CUSIP No. 89620X506 | SCHEDULE 13G | |
EXHIBIT B
JOINT FILING AGREEMENT
In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing with all other persons signatory below of a statement on Schedule 13G or any amendments thereto, with respect to the Common Stock of Trillium Therapeutics Inc. and that this Agreement be included as an attachment to such filing.
This Agreement may be executed in any number of counterparts each of which shall be deemed to be an original and all of which together shall be deemed to constitute one and the same Agreement.
IN WITNESS WHEREOF, the undersigned hereby execute this Agreement on the 11th day of February, 2016.
| | Merlin Biomed Private Equity Advisors, LLC | |
| | | | | |
| | | | | |
| | By: | /s/ Dominique Sémon | |
| | | Name: | Dominique Sémon | |
| | | Title: | Managing Member | |
| | | | | |
| | Merlin Nexus IV, L.P. | |
| | | | | |
| | By: | Merlin Nexus IV, LLC, General Partner | |
| | | | | |
| | By: | /s/ Dominique Sémon | |
| | | Name: | Dominique Sémon | |
| | | Title: | Managing Member | |
| | | | | |
| | Dominique Sémon | |
| | | | | |
| | | | | |
| | By: | /s/ Dominique Sémon | |
| | | Name: | Dominique Sémon | |
| | | | | |
